Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1

Rhea-AI Summary

Modular Medical (NASDAQ:MODD), an insulin delivery technology company, will participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024. The company, known for its FDA-cleared patch pump designed for adult 'almost-pumpers', will present a webcast at 2:00 p.m. Eastern Time on Tuesday, October 1. The webcast can be accessed via the conference home page and will be available for replay.

Additionally, Jeb Besser, Modular Medical's Chief Executive Officer, will host virtual one-on-one meetings with investors throughout the event. Interested parties can arrange meetings or register for the event through Lytham Partners.

SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its user-friendly and affordable design, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on October 1, 2024.

Company Webcast

The Company's webcasted presentation will take place at 2:00 p.m. Eastern Time on Tuesday, October 1. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2024/ and will also be available for replay following the event.

1×1 Meetings

Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2024invreg/.

About Modular Medical

Modular Medical, Inc. (Nasdaq: MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Modular Medical's mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property of their respective owners.

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View the original press release on accesswire.com

FAQ

When is Modular Medical (MODD) presenting at the Lytham Partners Fall 2024 Investor Conference?

Modular Medical (MODD) is presenting at the Lytham Partners Fall 2024 Investor Conference on October 1, 2024, at 2:00 p.m. Eastern Time.

How can investors access Modular Medical's (MODD) webcast presentation?

Investors can access Modular Medical's (MODD) webcast presentation by visiting the conference home page at https://lythampartners.com/fall2024/. The webcast will also be available for replay after the event.

Who will be hosting one-on-one meetings for Modular Medical (MODD) at the investor conference?

Jeb Besser, Modular Medical's (MODD) Chief Executive Officer, will be hosting virtual one-on-one meetings with investors throughout the Lytham Partners Fall 2024 Investor Conference.

How can investors arrange a meeting with Modular Medical's (MODD) CEO at the conference?

Investors can arrange a meeting with Modular Medical's (MODD) CEO by contacting Lytham Partners at 1x1@lythampartners.com or by registering for the event at https://lythampartners.com/fall2024invreg/.